These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10984262

  • 21. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone.
    Lanes R.
    Curr Pharm Biotechnol; 2000 Jul; 1(1):33-46. PubMed ID: 11467359
    [Abstract] [Full Text] [Related]

  • 22. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 23. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
    Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Shalet SM.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
    [Abstract] [Full Text] [Related]

  • 24. The importance of growth hormone replacement therapy for bone mass in young adults with growth hormone deficiency.
    Attie KM.
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():1011-21. PubMed ID: 11086656
    [Abstract] [Full Text] [Related]

  • 25. Spinal irradiation impairs the osteo-anabolic effects of low-dose GH replacement in adults with childhood-onset GH deficiency.
    Murray RD, Adams JE, Smethurst LE, Shalet SM.
    Clin Endocrinol (Oxf); 2002 Feb; 56(2):169-74. PubMed ID: 11874407
    [Abstract] [Full Text] [Related]

  • 26. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial.
    Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R.
    J Bone Miner Res; 2002 Jun; 17(6):1081-94. PubMed ID: 12054164
    [Abstract] [Full Text] [Related]

  • 27. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L, Kohlmeier L, Kent K, Marcus R.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
    [Abstract] [Full Text] [Related]

  • 28. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency.
    Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM.
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):627-33. PubMed ID: 7634504
    [Abstract] [Full Text] [Related]

  • 29. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency.
    Snyder PJ, Biller BM, Zagar A, Jackson I, Arafah BM, Nippoldt TB, Cook DM, Mooradian AD, Kwan A, Scism-Bacon J, Chipman JJ, Hartman ML.
    J Bone Miner Res; 2007 May; 22(5):762-70. PubMed ID: 17280527
    [Abstract] [Full Text] [Related]

  • 30. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 31. Bone markers and bone mineral density during growth hormone treatment in children with growth hormone deficiency.
    Cowell CT, Woodhead HJ, Brody J.
    Horm Res; 2000 Nov; 54 Suppl 1():44-51. PubMed ID: 11146379
    [Abstract] [Full Text] [Related]

  • 32. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
    Saggese G, Baroncelli GI, Bertelloni S, Barsanti S.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
    [Abstract] [Full Text] [Related]

  • 33. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
    Pincelli AI, Bragato R, Scacchi M, Branzi G, Osculati G, Viarengo R, Leonetti G, Cavagnini F.
    J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
    [Abstract] [Full Text] [Related]

  • 34. Growth hormone and bone health.
    Bex M, Bouillon R.
    Horm Res; 2003 May; 60 Suppl 3():80-6. PubMed ID: 14671403
    [Abstract] [Full Text] [Related]

  • 35. Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up.
    Finkenstedt G, Gasser RW, Höfle G, Watfah C, Fridrich L.
    Eur J Endocrinol; 1997 Mar; 136(3):282-9. PubMed ID: 9100553
    [Abstract] [Full Text] [Related]

  • 36. GH deficiency in the adult and bone.
    Doga M, Bonadonna S, Gola M, Mazziotti G, Nuzzo M, Giustina A.
    J Endocrinol Invest; 2005 Mar; 28(8 Suppl):18-23. PubMed ID: 16323825
    [Abstract] [Full Text] [Related]

  • 37. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.
    Degerblad M, Bengtsson BA, Bramnert M, Johnell O, Manhem P, Rosén T, Thorén M.
    Eur J Endocrinol; 1995 Aug; 133(2):180-8. PubMed ID: 7655642
    [Abstract] [Full Text] [Related]

  • 38. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density.
    Wüster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Ståhl E, Monson JP, Westberg B, Wilton P, KIMS Study Group and the KIMS International Board. Pharmacia & Upjohn International Metabolic Database.
    J Bone Miner Res; 2001 Feb; 16(2):398-405. PubMed ID: 11204440
    [Abstract] [Full Text] [Related]

  • 39. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ, Hamdy NA, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
    [Abstract] [Full Text] [Related]

  • 40. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
    Koranyi J, Svensson J, Götherström G, Sunnerhagen KS, Bengtsson B, Johannsson G.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.